Latest news
Rhythm Pharmaceuticals (RYTM) Reports Promising RM 718 Data, Is The Upside Already Priced In? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 17:36:26 GMTStructure Therapeutics Inc. (GPCR) Stock Analysis: Potential Upside of 116.78% Amid Promising Clinical Trials - DirectorsTalk InterviewsDirectorsTalk Interviews · Tue, 04 Aug 2026 09:19:54 GMTReplimune Group, Inc. (REPL) Investor Outlook: Potential Upside of 97.17% Amidst Promising Biotech Innovations - DirectorsTalk InterviewsDirectorsTalk Interviews · Fri, 31 Jul 2026 09:20:32 GMTShould You Buy Oracle Since it Promises 100% Upside at Consensus Target Price? - 24/7 Wall St.24/7 Wall St. · Wed, 29 Jul 2026 07:00:00 GMTMiMedx Group, Inc (MDXG) Stock Analysis: A Promising Potential Upside of Nearly 55% in the Healthcare Sector - DirectorsTalk InterviewsDirectorsTalk Interviews · Tue, 28 Jul 2026 09:20:47 GMTPromising biotech stocks with analyst upside targets of up to 242% By Investing.com - Investing.com South AfricaInvesting.com South Africa · Mon, 27 Jul 2026 20:34:42 GMTBuy These 3 Sales Growth Stocks With Promising Upside Potential - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTPromising biotech stocks with analyst upside targets of up to 242% - Investing.comInvesting.com · Mon, 27 Jul 2026 07:00:00 GMT